gp120 antibody
 gp120 Antibody |
|||
| 4641-002mg | ProSci | 0.02 mg | EUR 171.82 |
|
Description: gp120 Antibody: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
|||
gp120 Antibody |
|||
| 4641-01mg | ProSci | 0.1 mg | EUR 436.42 |
|
Description: gp120 Antibody: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
|||
gp120 Antibody |
|||
| 4777-002mg | ProSci | 0.02 mg | EUR 171.82 |
|
Description: gp120 Antibody: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
|||
gp120 Antibody |
|||
| 4777-01mg | ProSci | 0.1 mg | EUR 436.42 |
|
Description: gp120 Antibody: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
|||
gp120 Antibody |
|||
| 8677-002mg | ProSci | 0.02 mg | EUR 171.82 |
|
Description: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
|||
gp120 Antibody |
|||
| 8677-01mg | ProSci | 0.1 mg | EUR 436.42 |
|
Description: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
|||
 HIV1 gp120 antibody |
|||
| 10-2771 | Fitzgerald | 100 ug | EUR 337 |
|
Description: Monoclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
| 10-H30M | Fitzgerald | 100 ug | EUR 278 |
|
Description: Mouse monoclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
| 20R-2834 | Fitzgerald | 100 ul | EUR 813 |
|
Description: Rabbit polyclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
| 20-000401 | Fitzgerald | 500 ul | EUR 677 |
|
Description: Rabbit polyclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
| 20-000401F | Fitzgerald | 500 ul | EUR 410 |
|
Description: Rabbit polyclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
| 20-000402 | Fitzgerald | 100 ug | EUR 175 |
|
Description: Rabbit polyclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
| 20-HG81 | Fitzgerald | 1 mg | EUR 314 |
|
Description: Goat polyclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
| 20C-CR2102RP | Fitzgerald | 100 ug | EUR 689 |
|
Description: Rabbit polyclonal HIV1 gp120 antibody |
|||
 gp120 Peptide |
|||
| 4641P | ProSci | 0.05 mg | EUR 164.75 |
|
Description: (NT) gp120 peptide |
|||
gp120 Peptide |
|||
| 4777P | ProSci | 0.05 mg | EUR 164.75 |
|
Description: (IN) gp120 peptide |
|||
gp120 Peptide |
|||
| 8677P | ProSci | 0.05 mg | EUR 164.75 |
|
Description: gp120 Peptide |
|||
 HIV-1 gp120 Antibody |
|||
| 20-abx137505 | Abbexa |
|
|
HIV-1 gp120 Antibody |
|||
| 20-abx137103 | Abbexa |
|
|
HIV-1 gp120 Antibody |
|||
| 20-abx137183 | Abbexa |
|
|
HIV-1 gp120 Antibody |
|||
| abx023024-1ml | Abbexa | 1 ml | EUR 648 |
 SIV macC251 gp120 antibody |
|||
| 10R-S109a | Fitzgerald | 100 ug | EUR 597 |
|
Description: Mouse monoclonal SIV macC251, gp120 antibody |
|||
 SIV mac251 gp120 antibody |
|||
| 20-000111 | Fitzgerald | 500 ul | EUR 397 |
|
Description: Rabbit polyclonal SIV mac251 gp120 antibody |
|||
SIV mac251 gp120 antibody |
|||
| 20-000112 | Fitzgerald | 100 ug | EUR 322 |
|
Description: Rabbit polyclonal SIV mac251 gp120 antibody |
|||
) HIV1 gp120 antibody (HRP) |
|||
| 61-001002 | Fitzgerald | 50 ug | EUR 133 |
|
Description: Mouse monoclonal HIV1 gp120 antibody (HRP) |
|||
) HIV1 gp120 antibody (biotin) |
|||
| 61-001005 | Fitzgerald | 50 ug | EUR 403 |
|
Description: Mouse monoclonal HIV1 gp120 protein (biotin) |
|||
) HIV1 gp120 antibody (FITC) |
|||
| 60-00402-3 | Fitzgerald | 50 ug | EUR 168 |
|
Description: Rabbit polyclonal HIV1 gp120 antibody (FITC) conjugated |
|||
HIV1 gp120 antibody (biotin) |
|||
| 60-00402-5 | Fitzgerald | 50 ug | EUR 453 |
|
Description: Rabbit polyclonal HIV1 gp120 antibody (biotin) conjugated |
|||
HIV1 gp120 antibody (HRP) |
|||
| 60-H14 | Fitzgerald | 1 ml | EUR 409 |
|
Description: Goat polyclonal HIV1 gp120 antibody (HRP) conjugated |
|||
HIV1 gp120 antibody (biotin) |
|||
| 60C-CR1248GB | Fitzgerald | 1 ml | EUR 454 |
|
Description: Goat polyclonal HIV1 gp120 antibody (biotin) conjugated |
|||
 Antibody) Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody |
|||
| abx411417-1ml | Abbexa | 1 ml | EUR 509 |
Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody |
|||
| abx412175-1mg | Abbexa | 1 mg | EUR 509 |
 HIV-1 gp120 |
|||
| E62H004 | EnoGene | 100ug | EUR 382 |
 HIV1 gp120 protein |
|||
| 30-12001-2 | Fitzgerald | 100 ug | EUR 705 |
|
Description: Purified recombinant HIV1 gp120 protein |
|||
HIV1 gp120 protein |
|||
| 30-12001-4 | Fitzgerald | 1 mg | EUR 6289 |
|
Description: Purified recombinant HIV1 gp120 protein (HRP) |
|||
HIV1 gp120 protein |
|||
| 30-AH86 | Fitzgerald | 100 ug | EUR 1321 |
|
Description: Purified full length recombinant HIV1 gp120 protein-IIIB strain |
|||
 GP120 Recombinant Protein |
|||
| 96-365 | ProSci | 0.1 mg | EUR 516.5 |
|
Description: Human Immunodeficiency Virus (HIV) can be divided into two major types, HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV-1 is related to viruses found in chimpanzees and gorillas living in western Africa. HIV-2 is related to viruses found in sooty mangabeys. HIV-1 viruses may be further divided into groups. The HIV-1 group M viruses predominate and are responsible for the AIDS pandemic. Some of the HIV-1 group M subtypes are known to be more virulent or are resistant to different medications. HIV-2 viruses are thought to be less virulent and transmissible than HIV-1 M group viruses.Envelope glycoprotein GP120 (or gp120) is the name of the glycoprotein which forms the spikes sticking out of a HIV virus particle. gp120 is essential for virus entry into cells as it plays a vital role in seeking out specific cell surface receptors for entry. Three gp120s, bound as heterodimers to a transmembrane glycoprotein, gp41, are thought to combine in a trimer to form the envelope spike, which is involved in virus-cell attachment. One half of the molecular weight of gp120 is due to the carbohydrate side chains (the "glyco-" in "glycoprotein"). These are sugar residues which form something almost like a sugar "dome" over the gp120 spikes. This dome prevents gp120 from being recognised by the human immune response. As the HIV virus and the human CD4 cell come together, the gp120 binding site "snaps open" at the last minute.The glycoprotein gp120 is anchored to the viral membrane, or envelope, via non-covalent bonds with the transmembrane glycoprotein, gp41. It is involved in entry into cells by binding to CD4 receptors, particularly helper T-cells. Binding to CD4 is mainly electrostatic although there are van der Waals interactions and hydrogen bonds. |
|||
GP120 Recombinant Protein |
|||
| 96-366 | ProSci | 0.1 mg | EUR 516.5 |
|
Description: Human Immunodeficiency Virus (HIV) can be divided into two major types, HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV-1 is related to viruses found in chimpanzees and gorillas living in western Africa. HIV-2 is related to viruses found in sooty mangabeys. HIV-1 viruses may be further divided into groups. The HIV-1 group M viruses predominate and are responsible for the AIDS pandemic. Some of the HIV-1 group M subtypes are known to be more virulent or are resistant to different medications. HIV-2 viruses are thought to be less virulent and transmissible than HIV-1 M group viruses.Envelope glycoprotein GP120 (or gp120) is the name of the glycoprotein which forms the spikes sticking out of a HIV virus particle. gp120 is essential for virus entry into cells as it plays a vital role in seeking out specific cell surface receptors for entry. Three gp120s, bound as heterodimers to a transmembrane glycoprotein, gp41, are thought to combine in a trimer to form the envelope spike, which is involved in virus-cell attachment. One half of the molecular weight of gp120 is due to the carbohydrate side chains (the "glyco-" in "glycoprotein"). These are sugar residues which form something almost like a sugar "dome" over the gp120 spikes. This dome prevents gp120 from being recognised by the human immune response. As the HIV virus and the human CD4 cell come together, the gp120 binding site "snaps open" at the last minute.The glycoprotein gp120 is anchored to the viral membrane, or envelope, via non-covalent bonds with the transmembrane glycoprotein, gp41. It is involved in entry into cells by binding to CD4 receptors, particularly helper T-cells. Binding to CD4 is mainly electrostatic although there are van der Waals interactions and hydrogen bonds. |
|||
GP120 Recombinant Protein |
|||
| 96-367 | ProSci | 0.1 mg | EUR 595.25 |
|
Description: Human Immunodeficiency Virus (HIV) can be divided into two major types, HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV-1 is related to viruses found in chimpanzees and gorillas living in western Africa. HIV-2 is related to viruses found in sooty mangabeys. HIV-1 viruses may be further divided into groups. The HIV-1 group M viruses predominate and are responsible for the AIDS pandemic. Some of the HIV-1 group M subtypes are known to be more virulent or are resistant to different medications. HIV-2 viruses are thought to be less virulent and transmissible than HIV-1 M group viruses.Envelope glycoprotein GP120 (or gp120) is the name of the glycoprotein which forms the spikes sticking out of a HIV virus particle. gp120 is essential for virus entry into cells as it plays a vital role in seeking out specific cell surface receptors for entry. Three gp120s, bound as heterodimers to a transmembrane glycoprotein, gp41, are thought to combine in a trimer to form the envelope spike, which is involved in virus-cell attachment. One half of the molecular weight of gp120 is due to the carbohydrate side chains (the "glyco-" in "glycoprotein"). These are sugar residues which form something almost like a sugar "dome" over the gp120 spikes. This dome prevents gp120 from being recognised by the human immune response. As the HIV virus and the human CD4 cell come together, the gp120 binding site "snaps open" at the last minute.The glycoprotein gp120 is anchored to the viral membrane, or envelope, via non-covalent bonds with the transmembrane glycoprotein, gp41. It is involved in entry into cells by binding to CD4 receptors, particularly helper T-cells. Binding to CD4 is mainly electrostatic although there are van der Waals interactions and hydrogen bonds. |
|||
) HIV-1 gp120 Antibody (Biotin) |
|||
| abx023022-1ml | Abbexa | 1 ml | EUR 599 |
) HIV-1 gp120 Antibody (HRP) |
|||
| abx023023-1ml | Abbexa | 1 ml | EUR 662 |
) SIV mac251 gp120 antibody (FITC) |
|||
| 60-00112-3 | Fitzgerald | 50 ug | EUR 133 |
|
Description: Rabbit polyclonal SIV mac251 gp120 antibody (FITC) |
|||
) SIV mac251 gp120 antibody (biotin) |
|||
| 60-00112-5 | Fitzgerald | 50 ug | EUR 408 |
|
Description: Rabbit polyclonal SIV gp 120 antibody (biotin) |
|||
 Antibody (Biotin)) Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody (Biotin) |
|||
| abx411418-1ml | Abbexa | 1 ml | EUR 592 |
 Antibody (HRP)) Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody (HRP) |
|||
| abx411419-1ml | Abbexa | 1 ml | EUR 634 |
 Mouse antibody for HIV-1 gp120 |
|||
| 1996 | Virostat | 100 ug | EUR 354.5 |
|
Description: This is purified Mouse monoclonal antibody against HIV-1 gp120 for WB, ELISA. |
|||
 gp120, HIV-1 MN |
|||
| 5-01248 | CHI Scientific | 4 x 1mg | Ask for price |
 HIV-gp120-41-C |
|||
| 5-01323 | CHI Scientific | 4 x 1mg | Ask for price |
 HIV -gp120- Antigenic Peptide |
|||
| 5-01326 | CHI Scientific | 4 x 1mg | Ask for price |
HIV-gp120-41-C |
|||
| SP-100306-1 | Alpha Diagnostics | 1 mg | EUR 164 |
 Antigenic Peptide) HIV (gp120) Antigenic Peptide |
|||
| H-2982.0500 | Bachem | 0.5mg | EUR 405 |
|
Description: Sum Formula: C117H211N41O31S; CAS# [198636-94-1] net |
|||
HIV (gp120) Antigenic Peptide |
|||
| H-2982.1000 | Bachem | 1.0mg | EUR 708 |
|
Description: Sum Formula: C117H211N41O31S; CAS# [198636-94-1] net |
|||
 Goat Anti-HIV-1 gp120 Polyclonal Antibody |
|||
| DPAB0252 | Creative Diagnostics | 1 ml | EUR 741 |
Goat Anti-HIV-1 gp120 Polyclonal Antibody |
|||
| DPAB0253 | Creative Diagnostics | 1 ml | EUR 781 |
Goat Anti-HIV-1 gp120 Polyclonal Antibody |
|||
| DPAB0254 | Creative Diagnostics | 1 ml | EUR 833 |
 HIV-gp120-41-N-A |
|||
| 5-01324 | CHI Scientific | 4 x 1mg | Ask for price |
 HIV-gp120-41-N-B |
|||
| 5-01325 | CHI Scientific | 4 x 1mg | Ask for price |
) HIV -gp120- Fragment (254-274) |
|||
| 5-01327 | CHI Scientific | 4 x 1mg | Ask for price |
) HIV-gp120- Fragment (308-331) |
|||
| 5-01328 | CHI Scientific | 4 x 1mg | Ask for price |
) HIV-gp120-Fragment (318-327) |
|||
| 5-01329 | CHI Scientific | 4 x 5mg | Ask for price |